Liver check-ups
Study-related visits, lab work, and liver scans such as FibroScan are provided at no cost.
Now enrolling in Brooksville
For adults with compensated cirrhosis linked to fatty liver disease (MASH or NASH) — including people who are overweight or have type 2 diabetes, high blood pressure, or high cholesterol. The study is testing an investigational once-weekly study medication.
11373 Cortez Blvd, Brooksville · next to Oak Hill Hospital
Step 1 of 2
Here’s exactly who we’re looking for
You don't need your records handy. An ARI coordinator can review what you already know and check the details with you.
Told you have liver scarring, but not cirrhosis? ARI has a related study for earlier-stage scarring. Answer the questions anyway — the coordinator will check which study may fit.
What participants get
The study is testing whether an investigational once-weekly injection may help people with compensated MASH cirrhosis. It is given in addition to your usual medicines. There is no guarantee it will help, and taking part is always your choice.
Study-related visits, lab work, and liver scans such as FibroScan are provided at no cost.
The investigational study medication or placebo is provided at no cost. No insurance is needed.
A dedicated study team at Access Research Institute guides you through each visit and answers your questions.
Transportation to and from study visits can be arranged at no cost if you need it.
Compensation provided for your time. The coordinator can explain the details.
How it works
Tell us about your liver. It takes about a minute.
ARI reviews your answers and talks through the study with you.
If the study may fit, the next step is a no-cost screening visit at our Brooksville office.
Review the details, ask questions, and decide whether you want to join.
Common questions
Short answers about cost, placebo, the study medication, visits, and what comes next.
Call (352) 691-1140No. Study-related visits, tests, and study medication are provided at no cost, and you do not need insurance to take part. Compensation provided for your time.
It means the liver is scarred but still doing its main jobs, and you have never had complications such as fluid build-up in the belly, liver-related confusion, or bleeding from swollen veins. If you're not sure, the coordinator can help.
No. Answering the questions only lets Access Research Institute know you may be interested. You can ask questions and decide later, and you can leave the study at any time. Your information is handled under our privacy policy.
Possibly. About 2 out of every 3 participants receive the investigational study medication and about 1 out of 3 receive a placebo (an injection with no active medicine). Neither you nor the study team chooses which.
As a small injection under the skin once a week, in addition to your usual medicines. The study team will show you how it works.
Usually, yes — the study medication is added to your usual care. Some medicines may not be allowed. Don't change anything on your own; the study doctor will go over your list with you.
Screening usually includes a check-up, blood tests, and a liver scan such as FibroScan. The team reviews any past biopsy or scan results too, and explains every step before you decide.
This is a long-term study, expected to run about 4 to 5 years, though it may end sooner or later. You can stop at any time.
ARI also has a study for earlier-stage scarring. Answer the questions and the coordinator will check which study may fit.
Access Research Institute is on Cortez Blvd, next to Oak Hill Hospital. Transportation to and from study visits can be arranged at no cost.
Four quick questions
No commitment. An ARI coordinator will explain the details and answer your questions before you decide.
See if you may qualify